Conference Alert: Influenza
Category: Microbiology Conferences | Microbiology Conference | Microbiology Symposium | Microbiology Symposia
December 2 - 4, 2010 Influenza: Translating basic insights
Washington, DC, USA Further information
Organised by Cell Symposia.This meeting aims to bring basic scientists, clinicians, epidemiologists and applied biotechnology and pharmaceutical researchers together to build a translational bridge between basic influenza research and the development of drugs, vaccines and diagnostics for the flu.
Suggested reading: Influenza: Molecular Virology
Washington, DC, USA Further information
Organised by Cell Symposia.This meeting aims to bring basic scientists, clinicians, epidemiologists and applied biotechnology and pharmaceutical researchers together to build a translational bridge between basic influenza research and the development of drugs, vaccines and diagnostics for the flu.
Suggested reading: Influenza: Molecular Virology
Another Influenza Book Review
Category: Book Review
I am pleased to provide the following excerpt from a book review of Influenza: Molecular Virology:
"I particularly enjoyed a very thorough account of the influenza A haemagglutinin ... it's a nicely put together book that summarizes recent developments on the structural side of influenza replication. Appropriate audiences for the book would be final-year virology students and influenza researchers." from Paul Digard (University of Cambridge, UK) writing in Microbiol. Today (2010) read more ...
"I particularly enjoyed a very thorough account of the influenza A haemagglutinin ... it's a nicely put together book that summarizes recent developments on the structural side of influenza replication. Appropriate audiences for the book would be final-year virology students and influenza researchers." from Paul Digard (University of Cambridge, UK) writing in Microbiol. Today (2010) read more ...
 | Edited by: Qinghua Wang and Yizhi Jane Tao "a nicely put together book" (Microbiol. Today)ISBN: 978-1-904455-57-8 Publisher: Caister Academic Press Publication Date: February 2010 Cover: hardback |
Influenza Book Review
Category: Book Review
I am pleased to provide the following excerpt from a book review of Influenza: Molecular Virology:
"a series of excellent and high-powered articles on the molecular virology of influenza ... provides an up-to-date review of the advancements in molecular influenza virology, with additional discussions regarding the use of molecular technology in diagnostic platforms, and statistical modeling to quantify antigenic differences between influenza viruses ... of interest to a range of readers including post-graduate and basic science researchers, virologists and those involved with drug design and development." from Iain Stephenson (Leicester Royal Infirmary, Leicester, UK) writing in Expert Rev. Vaccines (2010) 9: 719-720. read more ...
"a series of excellent and high-powered articles on the molecular virology of influenza ... provides an up-to-date review of the advancements in molecular influenza virology, with additional discussions regarding the use of molecular technology in diagnostic platforms, and statistical modeling to quantify antigenic differences between influenza viruses ... of interest to a range of readers including post-graduate and basic science researchers, virologists and those involved with drug design and development." from Iain Stephenson (Leicester Royal Infirmary, Leicester, UK) writing in Expert Rev. Vaccines (2010) 9: 719-720. read more ...
| Edited by: Qinghua Wang and Yizhi Jane Tao "a series of excellent and high-powered articles" (Expert Rev. Vaccines)ISBN: 978-1-904455-57-8 Publisher: Caister Academic Press Publication Date: February 2010 Cover: hardback |
Influenza Conference
Category: Virology | Conferences | Microbiology Conference | Microbiology Conferences | Virology Conferences
September 11 - 14, 2010 Fourth ESWI International Conference
Malta Further information
Fourth ESWI International Conference devoted to influenza to be held in Malta.The meeting will provide comprehensive scientific coverage of all disciplines involved in influenza prevention, control and treatment. Top-level scientific sessions with specific attention for new developments are the core of the conference. Additionally, the conference has a clearly delineated programme for public health officials and opinion leaders in health care work. These sessions also cover a broad field of interest and will certainly include an evaluation of the H1N1 influenza pandemic.
Suggested reading: Influenza: Molecular Virology
Malta Further information
Fourth ESWI International Conference devoted to influenza to be held in Malta.The meeting will provide comprehensive scientific coverage of all disciplines involved in influenza prevention, control and treatment. Top-level scientific sessions with specific attention for new developments are the core of the conference. Additionally, the conference has a clearly delineated programme for public health officials and opinion leaders in health care work. These sessions also cover a broad field of interest and will certainly include an evaluation of the H1N1 influenza pandemic.
Suggested reading: Influenza: Molecular Virology
Intralymphatic Vaccination
Category: Vaccines | Immunology
Intralymphatic Vaccination
from Thomas M. Kündig, Pal Johansen, and Gabriela Senti writing in Vaccine Design: Innovative Approaches and Novel Strategies
The immune response is initiated by dendritic cells (DCs) and other antigen-presenting cells. These cells are present in nearly all organs and tissues of the body, so that theoretically any organ or tissue could serve as a route for vaccine administration. The choice of route is therefore mainly based on practical aspects. Using conventional needle and syringe the subcutaneous or intramuscular route are standard. The dermis and especially the epidermis are technically more difficult to target, but are likely to gain more interest due to the recent development of micro-needle patches and needle free injection devices. Vaccine administration via mucosal surfaces such as nasal or oral vaccination represents another option for needle free vaccine administration. While all the above mentioned routes of administration have been proven to work and protect against childhood diseases, influenza and many other infectious agents, the discussion and comparison of these different routes usually focuses on patient convenience, reduction of pain and distress for children, cost and on the possibility for mass vaccination. However, the route of administration can enhance the efficacy of vaccination. Especially in therapeutic vaccination, i.e., in a smaller patient number that already suffers from a disease, vaccination efficiency rather than convenience is the main issue. This is particularly the case in therapeutic cancer vaccines and in allergen specific immunotherapy. Intralymphatic vaccination is a strategy to maximize immunogenicity and therefore vaccine efficacy.
Further reading: Vaccine Design: Innovative Approaches and Novel Strategies
from Thomas M. Kündig, Pal Johansen, and Gabriela Senti writing in Vaccine Design: Innovative Approaches and Novel Strategies
The immune response is initiated by dendritic cells (DCs) and other antigen-presenting cells. These cells are present in nearly all organs and tissues of the body, so that theoretically any organ or tissue could serve as a route for vaccine administration. The choice of route is therefore mainly based on practical aspects. Using conventional needle and syringe the subcutaneous or intramuscular route are standard. The dermis and especially the epidermis are technically more difficult to target, but are likely to gain more interest due to the recent development of micro-needle patches and needle free injection devices. Vaccine administration via mucosal surfaces such as nasal or oral vaccination represents another option for needle free vaccine administration. While all the above mentioned routes of administration have been proven to work and protect against childhood diseases, influenza and many other infectious agents, the discussion and comparison of these different routes usually focuses on patient convenience, reduction of pain and distress for children, cost and on the possibility for mass vaccination. However, the route of administration can enhance the efficacy of vaccination. Especially in therapeutic vaccination, i.e., in a smaller patient number that already suffers from a disease, vaccination efficiency rather than convenience is the main issue. This is particularly the case in therapeutic cancer vaccines and in allergen specific immunotherapy. Intralymphatic vaccination is a strategy to maximize immunogenicity and therefore vaccine efficacy.
Further reading: Vaccine Design: Innovative Approaches and Novel Strategies
Vaccine Adjuvants
Category: Vaccines | Immunology
Vaccine Adjuvants
from David A. G. Skibinski and Derek T. O'Hagan writing in Vaccine Design: Innovative Approaches and Novel Strategies
The development of new effective vaccines, especially those consisting of highly purified antigens, will increasingly require the inclusion of an adjuvant. With over half a century of experience, aluminium containing adjuvants (alum) will continue to be widely used and until very recently remained the only vaccine adjuvant approved for human use in the US. In recent years a number of studies have started to reveal a more detailed understanding of alum's mechanism of action. There is a the need for more potent adjuvants than alum, with particular emphasis on the discovery and development of MF59, an emulsion based vaccine adjuvant which as been licensed for more than ten years in more than 20 countries, for use in an influenza vaccine focused on elderly subjects (Fluad).
Further reading: Vaccine Design: Innovative Approaches and Novel Strategies
from David A. G. Skibinski and Derek T. O'Hagan writing in Vaccine Design: Innovative Approaches and Novel Strategies
The development of new effective vaccines, especially those consisting of highly purified antigens, will increasingly require the inclusion of an adjuvant. With over half a century of experience, aluminium containing adjuvants (alum) will continue to be widely used and until very recently remained the only vaccine adjuvant approved for human use in the US. In recent years a number of studies have started to reveal a more detailed understanding of alum's mechanism of action. There is a the need for more potent adjuvants than alum, with particular emphasis on the discovery and development of MF59, an emulsion based vaccine adjuvant which as been licensed for more than ten years in more than 20 countries, for use in an influenza vaccine focused on elderly subjects (Fluad).
Further reading: Vaccine Design: Innovative Approaches and Novel Strategies
Influenza book review
Category: Book Review
I am pleased to provide the following excerpt from a book review of Influenza: Molecular Virology:
"This is a good quality, concise book on the basic nature of influenza viruses that comprehensively covers the current work on influenza." from Rebecca T. Horvat (University of Kansas Medical Center) writing in Doodys read more ...
"This is a good quality, concise book on the basic nature of influenza viruses that comprehensively covers the current work on influenza." from Rebecca T. Horvat (University of Kansas Medical Center) writing in Doodys read more ...
| Edited by: Qinghua Wang and Yizhi Jane Tao ISBN: 978-1-904455-57-8 Publisher: Caister Academic Press Publication Date: February 2010 Cover: Hardback |
New Influenza Book
The new book "Influenza: Molecular Virology" edited by Qinghua Wang and Yizhi Jane Tao has been just been published and is available for immediate dispatch read more ...
| Edited by: Qinghua Wang and Yizhi Jane Tao ISBN: 978-1-904455-57-8 Publisher: Caister Academic Press Publication Date: February 2010 Cover: Hardback read more ... |